AEROSOLIZED ACTIVE AGENT DELIVERY
The present invention is directed to methods and devices for delivering an active agent formulation to the lung of a human patient. The active agent formulation may be in dry powder form, it may be nebulized, or it may be in admixture with a propellant. The active agent formulation is delivered to a...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | CLARK, ANDREW FOULDS, GEORGE H |
| description | The present invention is directed to methods and devices for delivering an active agent formulation to the lung of a human patient. The active agent formulation may be in dry powder form, it may be nebulized, or it may be in admixture with a propellant. The active agent formulation is delivered to a patient at an inspiratory flow rate of less than 17 liters per minute. The bioavailability of the active agent was found to increase at these flow rates when compared to inspiratory flow rates of 17 liters per minute or more. |
| format | Patent |
| fullrecord | <record><control><sourceid>uspatents_EFI</sourceid><recordid>TN_cdi_uspatents_applications_20030183228</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20030183228</sourcerecordid><originalsourceid>FETCH-uspatents_applications_200301832283</originalsourceid><addsrcrecordid>eNrjZFB0dA3yD_b38YxydVFwdA7xDHNVcHR39QtRcHH1AXKCInkYWNMSc4pTeaE0N4Omm2uIs4duaXFBYklqXklxfGJBQU5mcmJJZn5ecbyRgYGxgaGFsZGRhTEpagHe7ClC</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>AEROSOLIZED ACTIVE AGENT DELIVERY</title><source>USPTO Published Applications</source><creator>CLARK, ANDREW ; FOULDS, GEORGE H</creator><creatorcontrib>CLARK, ANDREW ; FOULDS, GEORGE H</creatorcontrib><description>The present invention is directed to methods and devices for delivering an active agent formulation to the lung of a human patient. The active agent formulation may be in dry powder form, it may be nebulized, or it may be in admixture with a propellant. The active agent formulation is delivered to a patient at an inspiratory flow rate of less than 17 liters per minute. The bioavailability of the active agent was found to increase at these flow rates when compared to inspiratory flow rates of 17 liters per minute or more.</description><language>eng</language><creationdate>2003</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/20030183228$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,776,869,881,64035</link.rule.ids><linktorsrc>$$Uhttps://patentcenter.uspto.gov/applications/09266720$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CLARK, ANDREW</creatorcontrib><creatorcontrib>FOULDS, GEORGE H</creatorcontrib><title>AEROSOLIZED ACTIVE AGENT DELIVERY</title><description>The present invention is directed to methods and devices for delivering an active agent formulation to the lung of a human patient. The active agent formulation may be in dry powder form, it may be nebulized, or it may be in admixture with a propellant. The active agent formulation is delivered to a patient at an inspiratory flow rate of less than 17 liters per minute. The bioavailability of the active agent was found to increase at these flow rates when compared to inspiratory flow rates of 17 liters per minute or more.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2003</creationdate><recordtype>patent</recordtype><sourceid>EFI</sourceid><recordid>eNrjZFB0dA3yD_b38YxydVFwdA7xDHNVcHR39QtRcHH1AXKCInkYWNMSc4pTeaE0N4Omm2uIs4duaXFBYklqXklxfGJBQU5mcmJJZn5ecbyRgYGxgaGFsZGRhTEpagHe7ClC</recordid><startdate>20031002</startdate><enddate>20031002</enddate><creator>CLARK, ANDREW</creator><creator>FOULDS, GEORGE H</creator><scope>EFI</scope></search><sort><creationdate>20031002</creationdate><title>AEROSOLIZED ACTIVE AGENT DELIVERY</title><author>CLARK, ANDREW ; FOULDS, GEORGE H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_applications_200301832283</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2003</creationdate><toplevel>online_resources</toplevel><creatorcontrib>CLARK, ANDREW</creatorcontrib><creatorcontrib>FOULDS, GEORGE H</creatorcontrib><collection>USPTO Published Applications</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CLARK, ANDREW</au><au>FOULDS, GEORGE H</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>AEROSOLIZED ACTIVE AGENT DELIVERY</title><date>2003-10-02</date><risdate>2003</risdate><abstract>The present invention is directed to methods and devices for delivering an active agent formulation to the lung of a human patient. The active agent formulation may be in dry powder form, it may be nebulized, or it may be in admixture with a propellant. The active agent formulation is delivered to a patient at an inspiratory flow rate of less than 17 liters per minute. The bioavailability of the active agent was found to increase at these flow rates when compared to inspiratory flow rates of 17 liters per minute or more.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_uspatents_applications_20030183228 |
| source | USPTO Published Applications |
| title | AEROSOLIZED ACTIVE AGENT DELIVERY |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T21%3A41%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFI&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CLARK,%20ANDREW&rft.date=2003-10-02&rft_id=info:doi/&rft_dat=%3Cuspatents_EFI%3E20030183228%3C/uspatents_EFI%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |